Does Warfarin Interact with Adalimumab Atto?
CDI records a moderate classification for Warfarin and Adalimumab Atto. The stored summary is: AMJEVITA may influence CYP450 enzyme formation; monitoring of warfarin effect and dose adjustment recommended. The mechanism involves antagonism of cytokine activity may suppress cyp450 enzyme formation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Adalimumab Atto Class
- Tumor Necrosis Factor Blocker
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Antagonism of cytokine activity may suppress CYP450 enzyme formation
What To Tell Your Doctor or Pharmacist
If you are taking Warfarin and your doctor is considering prescribing Adalimumab Atto (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider